ASIA PACIFIC
English
English
Europe
- EUROPE - English
- CZECHIA - Čeština
- DANMARK - Dansk
- DEUTSCHLAND - Deutsch
- ESPAÑA - Español
- FRANCE - Français
- HRVATSKA - Hrvatski
- ITALIA - Italiano
- LATVIJA - Latviešu
- LIETUVA - Lietuvių
- MAGYARORSZÁG - Magyar
- NEDERLAND - Nederlands
- ÖSTERREICH - Deutsch
- POLSKA - Polski
- PORTUGAL - Português
- SCHWEIZ - Deutsch
- SLOVENSKO - Slovenčina
- SLOVENIJA - Slovenščina
- SUOMI - Suomi
- SCHWEIZ - Français
- UK - English
- ΕΛΛΆΔΑ - Ελληνικά
- БЪЛГАРИЯ - Български
- СРБИЈА - Српски
- УКРАЇНА - Українська
- TÜRKIYE - Türkçe
- РОССИЯ - Русский
- БЕЛАРУСЬ - Русский
Asia
Middle East and North Africa
USA, Latin America
Validation and Compliance of a Home Monitoring Device in Pregnancy: Microlife WatchBP Home
Chung Y., de Greeff A., Shennan A., 2009; 28: 348-59.
Objective
To assess the accuracy and patient compliance in using a novel home blood pressure monitoring device in high-risk pregnancy.
Results
The device achieved a mean difference ± SD of 0.4 ± 7.3/ −0.4 ± 5.5 mmHg (pregnancy) and −2.6 ± 7.0/0.8 ± 4.4 mmHg (preeclampsia) for systolic/ diastolic pressure. Eighty-one percent of women did at least 6 measurements/day and all women did at least 2 measurements/week.
Conclusions
The Microlife WatchBP Home is accurate for use in pregnancy and increases surveillance in compliant patients.
Related product
Customer support
Contact customer support if you would like our friendly agents to help you resolve your issues.
find support